Shots:

• GSK to receive 68% equity stake and Pfizer to receive 32% equity stake in consumer health business joint venture
• The focus of the agreement is to establish a joint venture using emphasizing on pharmaceuticals- vaccines and consumer healthcare products with use of genetics and technologies
• The consumer healthcare business unit will focus on OTC products including Pain Relief- Respiratory- Vitamin and Mineral Supplements- Digestive Health- Skin Health and Therapeutic Oral Health

Ref: GSK | Image: GSK